New Stanford regimen frees kidney-transplant patients from dependency on immunosuppresant drugs

Investigators at the Stanford University School of Medicine have developed a novel protocol that allows kidney-transplant recipients to jettison their indispensable immune-suppressing drugs. The protocol could also spell substantial savings to the health-care system.

Read the whole article on Physorg

More from Physorg